We first compared PDLIM3 expression in different carcinomas and nontumor tissues via Oncomine data, finding that relative to nontumor tissues, PDLIM3 expression was elevated in esophageal, brain and CNS, kidney, gastric, pancreatic, liver cancer, lymphoma, and sarcoma (Figure 1(a)). Here, PDLIM3 is linked to carcinoma.